Dutch labor leaders sue Merck over job cuts

The works council of Merck's (NYSE: MRK) Dutch R&D operations is taking the U.S. pharmaceutical firm to court over planned job cuts in the Netherlands, a works council spokesman said Friday. Report

Suggested Articles

After years of having first-line liver cancer market to itself, Bayer’s Nexavar is getting major competition from Roche's Tecentriq.

Most of the recent enthusiasm around AbbVie’s new drugs has centered on Skyrizi and Rinvoq, but elagolix wants a piece of the spotlight, too.

During David Loew's tenure, Sanofi Pasteur bought Protein Sciences, whose recombinant technology is being applied to a COVID-19 vaccine.